These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12555454)

  • 1. [Don't forget antacids!].
    Berstad A
    Tidsskr Nor Laegeforen; 2002 Aug; 122(20):2034. PubMed ID: 12555454
    [No Abstract]   [Full Text] [Related]  

  • 2. [Guidelines for good practice: anti-ulcer agents, indications in the adult. French Agency for Health Safety of Health Products].
    Therapie; 1999; 54(5):509-17. PubMed ID: 10667082
    [No Abstract]   [Full Text] [Related]  

  • 3. [Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients].
    Søndergaard B; Bytzer P
    Ugeskr Laeger; 2005 Jan; 167(5):500-2. PubMed ID: 15745170
    [No Abstract]   [Full Text] [Related]  

  • 4. [How to diagnose functional (non-ulcerative) dyspepsia (review)].
    Maev IV; B'iuchnova ES; Lebedeva EG; Iakimova SS
    Ter Arkh; 2004; 76(11):57-60. PubMed ID: 15658539
    [No Abstract]   [Full Text] [Related]  

  • 5. [Is the successful eradication of Helicobacter pylori sufficient for the healing of peptic ulcer?].
    Pregun I; Herszényi L; Juhász M; Miheller P; Tulassay Z
    Orv Hetil; 2006 Mar; 147(10):435-9. PubMed ID: 16573172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk factor Helicobacter pylori. Prevention of stomach carcinoma].
    MMW Fortschr Med; 2005 May; 147(20):53. PubMed ID: 15957864
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of dyspepsia and peptic ulcer disease.
    Ryan SW
    Altern Ther Health Med; 2005; 11(5):26-9; quiz 30. PubMed ID: 16189945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Eradication of Helicobacter pylori and use of antisecretory drugs--a population based study].
    Lassen AT; Hallas J; Schaffalitzky de Muckadell OB
    Ugeskr Laeger; 2004 Sep; 166(39):3405-7. PubMed ID: 15515395
    [No Abstract]   [Full Text] [Related]  

  • 9. Ulcers and gastritis.
    Pang SH; Leung WK; Graham DY
    Endoscopy; 2008 Feb; 40(2):136-9. PubMed ID: 18058616
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antacids and peptic ulcer].
    Vianello F; Di Mario F; Naccarato R
    G Clin Med; 1990 Feb; 71(2):123-6, 129-31. PubMed ID: 2189774
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of Levadial in the treatment of ulcer disease].
    Campesato A
    Minerva Gastroenterol; 1975; 21(3):155-60. PubMed ID: 1103006
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of Helicobacter pylori eradication on chronic use of acid-suppressant medication by patients in general practice; a randomised, double-blind study].
    Hurenkamp GJ; Grundmeijer HG; van der Ende A; Tytgat GN; Assendelft WJ; van der Hulst RW
    Ned Tijdschr Geneeskd; 2004 Nov; 148(48):2390-6. PubMed ID: 15615275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptic ulcer recurrence and Helicobacter pylori: evidence from Japan.
    Tsuji S; Kawano S
    J Gastroenterol; 2003; 38(4):410-1. PubMed ID: 12743786
    [No Abstract]   [Full Text] [Related]  

  • 14. [Eradication therapy. Is there a flip side to the medal?].
    MMW Fortschr Med; 2004 Jun; 146(24):55. PubMed ID: 15366503
    [No Abstract]   [Full Text] [Related]  

  • 15. [Helicobacter eradication in gastritis and ulcers. Causal therapy, prevention of stomach cancer].
    MMW Fortschr Med; 2003 Aug; 145(33-34):54-5. PubMed ID: 14526576
    [No Abstract]   [Full Text] [Related]  

  • 16. Refractory peptic ulcer disease.
    Napolitano L
    Gastroenterol Clin North Am; 2009 Jun; 38(2):267-88. PubMed ID: 19446258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori as a class I carcinogen: physiopathology and management strategies.
    Vogiatzi P; Cassone M; Luzzi I; Lucchetti C; Otvos L; Giordano A
    J Cell Biochem; 2007 Oct; 102(2):264-73. PubMed ID: 17486575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of long-term half-dose famotidine therapy on corpus gastritis in peptic ulcer disease.
    Kamada T; Hata J; Kusunoki H; Sugiu K; Ito M; Tanaka S; Kawamura Y; Chayama K; Haruma K
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():99-104. PubMed ID: 15943855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [H. pylori eradication therapy compared with antisecretory non-eradication therapy for the prevention of recurrent bleeding stomach ulcer].
    Dam A; Schaffalitzky de Muckadell OB
    Ugeskr Laeger; 2005 Jan; 167(5):497-9. PubMed ID: 15745169
    [No Abstract]   [Full Text] [Related]  

  • 20. [Methods for increasing the efficacy and safety of Helicobacter pylori eradication regimens].
    Zakharova NV
    Eksp Klin Gastroenterol; 2006; (4):59-66. PubMed ID: 17269426
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.